Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.4 USD | +0.55% | -2.31% | -11.77% |
26/04 | S&P 500 Posts First Weekly Gain Since March as Tech, Consumer Discretionary Lead Rise on Better-Than-Expected Earnings | MT |
26/04 | Sector Update: Health Care Stocks Edge Higher Late Afternoon | MT |
Evolution of the average Target Price on Pfizer, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Pfizer, Inc.
JPMORGAN | Chris Schott |
BERENBERG | Kerry Holford |
Argus | |
Guggenheim | |
UBS | |
DZ BANK | Elmar Kraus |
JEFFERIES | Akash Tewari |
TD Cowen | |
Morgan Stanley | |
Cantor Fitzgerald | |
Truist Securities | |
Daiwa Securities | |
Wells Fargo Securities | |
Redburn | |
JPMorgan Chase | |
Barclays | |
Jefferies & Co. | |
Goldman Sachs | |
Credit Suisse | |
SVB Securities LLC | |
BMO Capital | |
HSBC | |
Berenberg Bank | |
BofA Securities | |
Atlantic Equities | |
Citigroup | |
Mizuho Securities | |
Atlantic Securities | |
SVB Leerink | |
Independent Research | |
RBC | |
RBC Capital Markets | |
J.P. Morgan Chase |
EPS Revisions
- Stock Market
- Equities
- PFE Stock
- Consensus Pfizer, Inc.